Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.240
-0.120 (-8.82%)
At close: Oct 16, 2026, 4:00 PM EDT
1.246
+0.006 (0.48%)
After-hours: Oct 16, 2026, 4:46 PM EDT
Codexis Revenue
Codexis had revenue of $14.92M in the quarter ending June 30, 2026, a decrease of -2.69%. This brings the company's revenue in the last twelve months to $77.68M, up 35.89% year-over-year. In the year 2025, Codexis had annual revenue of $70.39M with 18.61% growth. That makes Codexis the 24,589th largest company in the world by revenue and 3,460th in the United States.
Revenue (ttm)
$77.68M
Revenue Growth
+35.89%
P/S Ratio
1.85
Revenue / Employee
$532,048
Employees
146
Market Cap
135.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.39M | 11.04M | 18.61% |
| Dec 31, 2024 | 59.35M | -10.80M | -15.39% |
| Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
| Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
| Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
| Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
| Dec 31, 2019 | 68.46M | 7.86M | 12.98% |
| Dec 31, 2018 | 60.59M | 10.57M | 21.13% |
| Dec 31, 2017 | 50.02M | 1.19M | 2.43% |
| Dec 31, 2016 | 48.84M | 7.03M | 16.82% |
| Dec 31, 2015 | 41.80M | 6.50M | 18.40% |
| Dec 31, 2014 | 35.31M | 3.39M | 10.60% |
| Dec 31, 2013 | 31.92M | -56.38M | -63.85% |
| Dec 31, 2012 | 88.30M | -35.57M | -28.71% |
| Dec 31, 2011 | 123.87M | 16.76M | 15.65% |
| Dec 31, 2010 | 107.10M | 24.20M | 29.18% |
| Dec 31, 2009 | 82.91M | 32.43M | 64.25% |
| Dec 31, 2008 | 50.48M | 25.15M | 99.26% |
| Dec 31, 2007 | 25.33M | 13.21M | 108.90% |
| Dec 31, 2006 | 12.13M | 343.00K | 2.91% |
| Dec 31, 2005 | 11.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CDXS News
- 18 days ago - Codexis announces agreement with siRNA drug innovator - TheFly
- 18 days ago - Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA - GlobeNewsWire
- 5 weeks ago - Codexis Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - Codexis Slides: Corporate presentation - Filings
- 7 weeks ago - Codexis to Participate in Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 2 months ago - Codexis reports Q2 EPS (13c), consensus (12c) - TheFly
- 2 months ago - Codexis backs FY26 revenue view $72M-$76M, consensus $74.1M - TheFly
- 2 months ago - Codexis price target lowered to $8 from $9 at Piper Sandler - TheFly